Systemic treatment of psoriatic patients with bexarotene dec…
Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation%2525252C and improves differentiation in lesional skin.
Article, Chapter
Full text availability for this item
Collection:
Elsevier ScienceDirect Journals
Coverage:
- 1979-07~present